Literature DB >> 10568165

Interaction of acrylodan with human serum albumin. A fluorescence spectroscopic study.

F Moreno1, M Cortijo, J González-Jiménez.   

Abstract

The binding of the fluorescent probe acrylodan (AC) to human serum albumin (HSA) was studied by fluorescence spectroscopy. The binding isotherms could be fitted to two types of sites. Competition experiments using iodoacetamide suggested that AC binds tightly on HSA by the cysteine-34. Attempts were made to find the location of the second site using high concentrations of warfarin, phenylbutazone, diazepam, indomethacin, palmitic acid or bilirubin in order to displace the bound AC to the HSA. Bilirubin was the only ligand able to displace the bound AC. This result suggests that AC, which is a very hydrophobic molecule also capable of labeling lysine residues, should also bind the human albumin in the primary site of bilirubin, but with less affinity than to the cysteine-34.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10568165

Source DB:  PubMed          Journal:  Photochem Photobiol        ISSN: 0031-8655            Impact factor:   3.421


  4 in total

1.  Ultrafast hydration dynamics in protein unfolding: human serum albumin.

Authors:  J K Amisha Kamal; Liang Zhao; Ahmed H Zewail
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-07       Impact factor: 11.205

2.  Urea-induced denaturation of human serum albumin labeled with acrylodan.

Authors:  José González-Jiménez; Manuel Cortijo
Journal:  J Protein Chem       Date:  2002-02

3.  Resonance energy transfer between tryptophan-214 in human serum albumin and acrylodan, prodan, and promen.

Authors:  José González-Jiménez; Manuel Cortijo
Journal:  Protein J       Date:  2004-07       Impact factor: 2.371

4.  Bovine and human serum albumin interactions with 3-carboxyphenoxathiin studied by fluorescence and circular dichroism spectroscopy.

Authors:  Aurica Varlan; Mihaela Hillebrand
Journal:  Molecules       Date:  2010-06-01       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.